Proof of Concept Study for Designed Multiple Ligands Targeting the Dopamine D2, Serotonin 5-HT2A, and Muscarinic M1 Acetylcholine Receptors

被引：11
|
作者：
Szabo, Monika [1 ]
Lim, Herman D. [1 ]
Herenbrink, Carmen Klein [1 ]
Christopoulos, Arthur [1 ]
Lane, J. Robert [1 ]
Capuano, Ben [1 ]
机构：
[1] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 58卷 / 03期
基金：
英国医学研究理事会;
关键词：
ALLOSTERIC MODULATORS; AGONIST; DRUGS; ANTIPSYCHOTICS; DISCOVERY; MODES; LEAD;
D O I：
10.1021/jm5013243
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Herein we describe the hybridization of a benzoxazinone M-1 scaffold with D-2 privileged structures derived from putative and clinically relevant antipsychotics to develop designed multiple ligands. The M-1 mAChR is an attractive target for the cognitive deficits in key CNS disorders. Moreover, activity at D-2 and 5-HT2A receptors has proven useful for antipsychotic efficacy. We identified 9 which retained functional activity at the target M-1 mAChR and D2R and demonstrated high affinity for the 5-HT2AR.
引用
收藏
页码：1550 / 1555
页数：6
相关论文
共 50 条
  • [31] Targeting Dopamine D2, Adenosine A2A, and Glutamate mGlu5 Receptors to Reduce Repetitive Behaviors in Deer Mice
    Lewis, Mark H.
    Primiani, Christopher T.
    Muehlmann, Amber M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 369 (01) : 88 - 97
  • [32] Aripiprazole Offsets Mutant ATXN3-Induced Motor Dysfunction by Targeting Dopamine D2 and Serotonin 1A and 2A Receptors in C. elegans
    Jalles, Ana
    Vieira, Carmen
    Pereira-Sousa, Joana
    Vilasboas-Campos, Daniela
    Mota, Ana Francisca
    Vasconcelos, Sara
    Ferreira-Lomba, Bruna
    Costa, Marta Daniela
    Da Silva, Jorge Diogo
    Maciel, Patricia
    Teixeira-Castro, Andreia
    BIOMEDICINES, 2022, 10 (02)
  • [33] Actions of Novel Antipsychotic Agents on Apomorphine-Induced PPI Disruption: Influence of Combined Serotonin 5-HT1A Receptor Activation and Dopamine D2 Receptor Blockade
    Agnès L Auclair
    Mark S Kleven
    Joël Besnard
    Ronan Depoortère
    Adrian Newman-Tancredi
    Neuropsychopharmacology, 2006, 31 : 1900 - 1909
  • [34] Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity:: comparison with typical and atypical conventional antipsychotics
    Bardin, Laurent
    Auclair, Agnes
    Kleven, Mark S.
    Prinssen, Eric P. M.
    Koek, Wouter
    Newman-Tancredi, Adrian
    Depoortre, Ronan
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 (02): : 103 - 118
  • [35] Occupancy of dopamine D2 and D3 and serotonin 5-HT1A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography
    Seneca, Nicholas
    Finnema, Sjoerd J.
    Laszlovszky, Istvan
    Kiss, Bela
    Horvath, Attila
    Pasztor, Gabriella
    Kapas, Margo
    Gyertyan, Istvan
    Farkas, Sandor
    Innis, Robert B.
    Halldin, Christer
    Gulyas, Balazs
    PSYCHOPHARMACOLOGY, 2011, 218 (03) : 579 - 587
  • [36] DUAL ACTIVATION BY LISURIDE OF CENTRAL SEROTONIN 5-HT1A AND DOPAMINE D2 RECEPTOR-SITES - DRUG DISCRIMINATION AND RECEPTOR-BINDING STUDIES
    KIMURA, K
    AKAI, T
    NAKAMURA, K
    YAMAGUCHI, M
    NAKAGAWA, H
    OSHINO, N
    BEHAVIOURAL PHARMACOLOGY, 1991, 2 (02): : 105 - 112
  • [37] In Vivo Effects of Pardoprunox (SLV308), a Partial D2/D3 Receptor and 5-HT1A Receptor Agonist, on Rat Dopamine and Serotonin Neuronal Activity
    Betry, Cecile
    Etievant, Adeline
    Lambas-Senas, Laura
    Mccreary, Andrew C.
    Haddjeri, Nasser
    SYNAPSE, 2011, 65 (10) : 1042 - 1051
  • [38] Haloperidol Prevents Oxytosis/Ferroptosis by Targeting Lysosomal Ferrous Ions in a Manner Independent of Dopamine D2 and Sigma-1 Receptors
    Hirata, Yoko
    Oka, Kohei
    Yamamoto, Shotaro
    Watanabe, Hiroki
    Oh-hashi, Kentaro
    Hirayama, Tasuku
    Nagasawa, Hideko
    Takemori, Hiroshi
    Furuta, Kyoji
    ACS CHEMICAL NEUROSCIENCE, 2022, 13 (18): : 2719 - 2727
  • [39] Halogen bonding enhances activity in a series of dual 5-HT6/D2 ligands designed in a hybrid bioisostere generation/virtual screening protocol
    Staron, Jakub
    Warszycki, Dawid
    Kurczab, Rafal
    Satala, Grzegorz
    Bugno, Ryszard
    Hogendorf, Adam
    Bojarski, Andrzej J.
    RSC ADVANCES, 2016, 6 (60): : 54918 - 54925
  • [40] Actions of novel antipsychotic agents on apomorphine-induced PPI disruption:: Influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade
    Auclair, Agnes L.
    Kleven, Mark S.
    Besnard, Joel
    Depoortere, Ronan
    Newman-Tancredi, Adrian
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 (09) : 1900 - 1909
12345